We are live on ! Find out more
KMED

KraneShares Emerging Markets Healthcare Index ETF

Delisted

KMED was delisted on the 18th of October, 2023.

2 hedge funds and large institutions have $18K invested in KraneShares Emerging Markets Healthcare Index ETF in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 32 (-1)

95% less capital invested

Capital invested by funds: $379K → $18K (-$361K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$250

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$359K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$17K +$250 +10 +1%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$1K
Jane Street
3
Jane Street
New York
-$359K -12,912 Closed

KMED Hedge Fund Activity: Q1 2022 in Review

2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in KraneShares Emerging Markets Healthcare Index ETF (KMED) for Q1 2022, worth a combined $18K — down 95% from $379K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of KMED and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $250. The largest seller was Jane Street, exiting entirely with an estimated $359K sold.

  • 2 institutional investors held KraneShares Emerging Markets Healthcare Index ETF (KMED) as of Q1 2022, down from 3 in Q4 2021.
  • Funds reported $18K of KraneShares Emerging Markets Healthcare Index ETF stock for Q1 2022, down 95% quarter-over-quarter.
  • 0 funds opened new KraneShares Emerging Markets Healthcare Index ETF positions in Q1 2022 and 1 closed out, a net change of -1 holder.
  • The largest KraneShares Emerging Markets Healthcare Index ETF buyer in Q1 2022 was UBS Group, an estimated $250 added.
  • The largest KraneShares Emerging Markets Healthcare Index ETF seller in Q1 2022 was Jane Street, an estimated $359K sold.

Based on aggregated 13F filings for Q1 2022.